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Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder affecting the senile
population with manifestation of motor disability and cognitive impairment. Reactive oxygen species (ROS) is implicated
in the progression of oxidative stress-related apoptosis and cell death of the midbrain dopaminergic neurons. Its
interplay with mitochondrial functionality constitutes an important aspect of neuronal survival in the perspective of PD.
Edible bird’s nest (EBN) is an animal-derived natural food product made of saliva secreted by swiftlets from the
Aerodamus genus. It contains bioactive compounds which might confer neuroprotective effects to the neurons. Hence
this study aims to investigate the neuroprotective effect of EBN extracts in the neurotoxin-induced in vitro PD model.
Methods: EBN was first prepared into pancreatin-digested crude extract and water extract. In vitro PD model was
generated by exposing SH-SY5Y cells to neurotoxin 6-hydroxydopamine (6-OHDA). Cytotoxicity of the extracts on
SH-SY5Y cells was tested using MTT assay. Then, microscopic morphological and nuclear examination, cell viability
test and ROS assay were performed to assess the protective effect of EBN extracts against 6-OHDA-induced cellular
injury. Apoptotic event was later analysed with Annexin V-propidium iodide flow cytometry. To understand whether the
mechanism underlying the neuroprotective effect of EBN was mediated via mitochondrial or caspase-dependent
pathway, mitochondrial membrane potential (MMP) measurement and caspase-3 quantification were carried out.
Results: Cytotoxicity results showed that crude EBN extract did not cause SH-SY5Y cell death at concentrations
up to 75 μg/ml while the maximum non-toxic dose (MNTD) of water extract was double of that of crude extract.
Morphological observation and nuclear staining suggested that EBN treatment reduced the level of 6-OHDA-induced
apoptotic changes in SH-SY5Y cells. MTT study further confirmed that cell viability was better improved with crude EBN
extract. However, water extract exhibited higher efficacy in ameliorating ROS build up, early apoptotic membrane
phosphatidylserine externalization as well as inhibition of caspase-3 cleavage. None of the EBN treatment had any
effect on MMP.
Conclusions: Current findings suggest that EBN extracts might confer neuroprotective effect against 6-OHDA-induced
degeneration of dopaminergic neurons, particularly through inhibition of apoptosis. Thus EBN may be a viable
nutraceutical option to protect against oxidative stress-related neurodegenerative disorders such as PD.
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Parkinson’s disease (PD) is an age-related progressive
neurodegenerative disease with estimated worldwide
prevalence approaching 9 million of people over the age of
50 by 2030 [1]. Pathologically, there is loss of dopaminergic
neurons in the substantia nigra which subsequently causes
dopamine depletion in the striatum [2]. Abnormal ag-
gregation of α-synuclein known as Lewy bodies is also
detected in surviving neurons [3]. Dopamine depletion
ultimately leads to deterioration of motor functions
whereby the patients are often manifested with clinical
signs such as tremor, rigidity and slow responsiveness [4].
Several hypotheses including neuroinflammation, mito-
chondrial dysfunction, failure of ubiquitin-proteasome sys-
tem and proteinopathy have been proposed to explain the
neurodegeneration events in PD [5,6]. Amongst those,
oxidative stress-related apoptosis has been implicated
in the pathogenesis of neurodegenerative diseases. Oxida-
tive stress is caused by the production and accumulation of
excessive partially reduced reactive oxygen species (ROS)
within the cell, which attacks electron-rich biological mole-
cules such as DNA, protein and lipid to affect cellular
functions [7]. ROS is generated as a part of normal cellular
metabolism. In the cells with high oxygen-utilizing capacity
such as the neurons, however, greater amount of highly re-
active oxygen radical is being produced which renders
these cells more vulnerable to oxidative damages [8]. In
PD, substantial post-mortem studies noted that impaired
mitochondrial function and ROS build up are two events
linked to apoptotic episode in dopaminergic neurons [6,9].
Experimental models of PD which are generated through
the use of mitochondrial complex I activity-inhibiting and
ROS-inducing neurotoxins are able to recapitulate the
pathological features in PD, further reinforces that ROS
introduction is critically involved in the disease [10].
Therefore the brain requires an effective antioxidant sys-
tem to counteract the impact of ROS, as well as an anti-
apoptotic mechanism to maintain the neuronal integrity.
Edible bird nest (EBN) is natural food product made
from saliva of the swiftlets of the genus Aerodramus (or
Collocalia). Numerous in vitro and in vivo researches
have shown that administration of EBN was able to
boost immunity, promote cell division and proliferation,
neutralize influenza activity as well as improve osteopor-
osis [11-14]. Studies have shown that EBN contains the
bioactive compound sialic acid [15-17]. Furthermore,
EBN may also contain epidermal growth factor (EGF)
because EGF-like activity was detected in protein frac-
tions partially purified from EBN extract. In fact, sialic
acid and EGF are neurotrophic factors known to pro-
mote neuron and brain development [18-21]. On the
other hand, animal saliva was previously found to con-
tain vascular endothelial growth factor and melatonin
[22,23]. These compounds are powered with anti-apoptotic and antioxidant properties [24,25]. As apop-
tosis and oxidative stress have been suggested as cru-
cial events in neurodegeneration, EBN, the salivary
secretion of swiftlets, may have neuroprotective rele-
vance in the therapeutic context of PD. Nevertheless
no scientific investigation has been conducted thus far
to confirm this. Hence this study aimed to investigate
the neuroprotective effect of EBN.
Methods
Preparation of EBN extracts
Raw EBN from the swiftlet of Aerodamus genus collected
from bird’s nest farm in Perak, Malaysia was kindly pro-
vided by a local EBN distributor Yew Kee Pte Ltd. Clean-
ing was carried out by first soaking the unprocessed EBN
in ultrapure water until softened and protein strands be-
came slightly loosened. Dirt and feathers were removed
manually by forceps. Cleaned EBN was subsequently oven-
dried at 50°C before being grounded into fine powder. A
portion of cleaned EBN was kept for water extraction
whereby the EBN was first soaked in cold distilled water
for 48 hours followed by boiling at 100°C for 30 minutes.
The solution mixture was filtered and the filtrate was
freeze-dried with freeze dryer (EYELA Freeze Dryer FOU
2100) to obtain EBN water extract powder.
Traditionally, a bird’s nest soup was prepared by double-
boiling the cleaned EBN strands with water until softened,
whereby sugar is often added to enrich the taste. In the
current study, however, both raw EBN and its water ex-
tracts were prepared by enzymatic digestion using method
adopted from Guo et al. [13]. Pancreatin digestion was
performed as numerous studies have suggested that pro-
teolytic breakdown of EBN produced greater bioactivities
when compared to the undigested EBN [13,14]. This add-
itional step of enzymatic hydrolysis is suggested to enhance
solubilisation of bioactive compounds, which subsequently
leading to cellular assimilation. Briefly, raw EBN and water
extract powder dissolved in ultrapure water at 2.5% (w/v)
were digested with pancreatin (final concentration 0.5 mg/
ml) (Sigma Aldrich, USA) in a 45°C water bath for 4 hours
at pH 8.5- 9.0. Pancreatin enzyme was then deactivated at
90°C for 5 minutes. The mixtures were then filtered and
freeze-dried to obtain the final crude and water EBN ex-
tracts, which were denoted as S1 and S2 respectively. Fi-
nally, products were dissolved in dimethyl sulphoxide
(DMSO) (Sigma Aldrich, USA) as a stock of 50 mg/ml and
sonicated until the powder was fully solubilized. Then the
EBN solutions were centrifuged at 3000 rpm for 10 minutes
to precipitate the undissolved EBN particles. The super-
natant was collected and stored at -20°C for future use.
Neuronal cell culture
Human neuroblastoma cells SH-SY5Y was purchased
from the American Type Culture Collection (ATCC no.
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from Dulbecco’s Modified Eagle’s Medium (Gibco, UK)
supplemented with 10% fetal bovine serum (Gibco, UK).
The cells were maintained at 37°C humidified incubator
with 5% CO2 for 2-3 days until 70% confluent. Cell collec-
tion was carried out by rinsing the cells with phosphate-
buffered saline (PBS) (Biobasic, Canada) followed by
addition of trypsin-EDTA (Gibco, UK) to detach the cells.
The action of trypsin was later neutralized with complete
medium and cells were harvested by centrifugation at
1500 rpm for 5 minutes. The cells were then sub-cultured
into new tissue culture flask or plated for assays.
Determination of maximum non-toxic dose (MNTD) and ef-
fect of the EBN extracts on 6-OHDA-induced cytotoxicity
Cytotoxic test was performed with tetrazolium reduc-
tion assay using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) reagent (Sigma
Aldrich, USA). Cells were first seeded onto 96-well plate at
a density of 4 × 104 cells/well with complete medium,
which then was replaced by serum-free medium for treat-
ment in the next day. Cytotoxic effect of both crude and
water EBN extracts on SH-SY5Y cells was tested across a
wide range of concentrations from 0 to 500 μg/ml. DMSO,
which was used to dissolve the extracts, was included as
vehicle control. After 48 hours incubation, MTT solution
was added into the culture to a final concentration of
0.5 mg/ml. After 4 hours incubation at 37°C, the medium
was removed and replaced with equal volume of DMSO to
dissolve the purple formazan crystal. Absorbance of the so-
lution was measured spectrophotometrically with micro-
plate reader (DynexOpsys MR 24100) at 570 nm and was
compared to control to be presented in percentage of cell
viability or toxicity. MNTD and ½ MNTD of EBN extracts
were determined from graph plotted.
To determine the effect of EBN extracts on SH-SY5Y
intoxicated with neurotoxin, cells were pre-treated with
EBN extracts at MNTD and ½ MNTD for 24 hours
followed by co-incubation with 100 μM 6-OHDA for an-
other 24 hours. Upon completion of treatment, MTT
assay was performed to determine the cell viability. All
test assays followed the same treatment whereby DMSO
alone (0.5% v/v) was used as vehicle control.
Morphological examination
Apoptotic cells experiencing damage in the nuclei are
featured by cell shrinkage, membrane blebbing and pres-
ence of apoptotic bodies [26]. In order to perform mor-
phological study, cells were first grown in 60 mm culture
dish and treated accordingly whereby groups such as ve-
hicle control, 6-OHDA, S1 MNTD+ 6-OHDA and S2
MNTD+ 6-OHDA were included. Then, cell morphology
was examined under bright field inverted microscope
(Nikon Eclipse Ti, Japan). In addition to that, nuclearstaining was performed with Hoechst staining. Treated
cells were fixed with 4% paraformaldehyde for 15 minutes
before stained with Hoechst 33258 (1 μg/ml) (Sigma
Aldrich, USA) for 15-20 minutes. Nuclear changes were
examined under fluorescence excitation using the same
microscope for features such as chromatin condensa-
tion, DNA fragmentation and cell shrinkage. Photomi-
crographs were taken using attaching camera.
Intracellular reactive oxygen species (ROS) level
measurement
Intracellular ROS production was assessed with 2′, 7′-
dichlorofluorescein diacetate (DCFH-DA) fluorescent
probe. Cells were seeded into 12-well plate at a density
of 1.5 × 105 cells/well. Upon completion of treatment,
cells were collected and washed before added with
40 μM DCFH-DA (Sigma Aldrich, USA) working solu-
tion in 96-well black plate. Fluorescence reading was
taken at 0, 10, 20 and 30 minutes with fluorescence mi-
croplate reader using excitation and emission wave-
lengths of 485 nm and 535 nm (Tecan, Austria). The
fluorescence readings were then normalized to the re-
spective cell number to give relative value of DCF fluor-
escence unit. Fold change in ROS production of the
treated groups was determined by comparing to the un-
treated control.
Apoptosis analysis
The procedure was performed with Annexin V-FITC
Apoptosis Detection Kit (BD Pharmingen, USA) using a
modified protocol by Rieger et al. [27]. Briefly, upon com-
pletion of treatments, cells were harvested and washed
with binding buffer. Cells were counted to obtain a final
concentration of 1 × 106 cells/ml. Then Annexin V and
propidium iodide (PI) were added and incubated in dark
for 15 minutes. After washing, cell suspension was fixed
with 1% formaldehyde for 10 minutes on ice. Subse-
quently, washing was performed twice with binding buffer
followed by addition of RNase (EMD Biosciences, USA)
which then incubated for 15 minutes at 37°C. Finally, sam-
ples were washed and ready for analysis with FACSCalibur
flow cytometer (BD Biosciences, USA) and the software
Cell Quest Pro.
Mitochondrial membrane potential measurement
Mitochondrial membrane potential (MMP or ΔΨm) is
an important indicator of mitochondrial functionality.
Apoptosis through mitochondrial-mediated pathway can
be assessed by performing MMP assay using MitoScreen
kit (BD Pharmingen, USA) according to the protocols
provided. Briefly, cells were collected by trypsinization
and centrifugation. Washing with PBS was carried out
and cells were counted to obtain a final concentration of
1 × 106 cells/ml. Working staining solution was prepared
Yew et al. BMC Complementary and Alternative Medicine 2014, 14:391 Page 4 of 12
http://www.biomedcentral.com/1472-6882/14/391from the JC-1 powdered dye and assay buffer at a ratio of
1:99, which was then added to the cells. Incubation was
carried out at 37°C in 5% CO2 incubator for 15 minutes.
Cells were washed twice in assay buffer before analyzed
with flow cytometer. Mitochondrial depolarization is indi-
cated by a decrease in the red JC aggregates/green JC
monomer fluorescence intensity ratio.
Caspase-3 detection
Caspase-3 is a proteolytic enzyme activated during apop-
tosis. It was detected using FITC active caspase-3 apop-
tosis kit (BD Pharmingen, USA) according to the protocol
provided. Cells were first collected by trypsinization and
centrifugation. Then, cells were washed with PBS twice
and resuspended in BD Cytofix/ Cytoperm™ fixation and
permeabilization solution at 1 × 106 cells/0.5 ml. Subse-
quently cells were incubated on ice for 20 minutes. Fix-
ation solution was discarded after centrifugation and cells
were washed twice with 0.5 ml of BD Perm/Wash™ buffer.
A hundred microliters of BD Perm/Wash™ buffer and
20 μl of FITC anti-active caspase-3 antibody were added to
each sample and incubated for 30 minutes at room
temperature. Then, cells were washed with 1 ml of BD
Perm/Wash™ buffer. Finally cells were resuspended in
0.5 ml of the same buffer and transferred to FACS tube for
flow cytometry analysis.
Statistical analysis
Data was collected as triplicate from at least 3 independent
experiments. The results were expressed as mean ± stand-
ard deviation. Statistical significance was assessed with
Student’s t-test. P value <0.05 was considered significant.
Results & Discussion
Cytotoxic profile of EBN extracts (S1 and S2)
Toxicity study was first performed with addition of EBN
extracts to SH-SY5Y cells to determine the concentration-
wide effect as well as MNTDs of the extracts on neuronal
culture. MNTD is the maximal dose just below the thresh-
old for cell toxicity that demonstrates no cytotoxic effect.
Half of the MNTD value was also determined in order to
study the effect of EBN treatment at lower concentration.
In the graph of cytotoxicity percentage in SH-SY5Y
cells against EBN extract concentration (Figure 1), it was
found that there was an increasing trend of cytotoxicity
along with the concentration. However, cell death was
not evident at concentration below 100 μg/ml for S1 and
200 μg/ml for S2. MNTDs are the concentrations at
which cytotoxicity starts to become evident (where line
touches x-axis). As determined from the graph, MNTDs
were 76.25 ± 16.52 μg/ml for S1 and 150 ± 36.06 μg/ml
for S2. Meanwhile the ½ MNTDs were 38.13 μg/ml and
75 μg/ml for S1 and S2, respectively. Overall the cyto-
toxicity of S1 was double as much as the cytotoxicity ofS2. Such discrepancy could be due to varying methods
employed in preparing the two extracts. In fact, com-
pound solubility and stability are major factors that con-
tribute to varied activities in different extracts [28]. S2
was extracted with water thus one might expect the
resulting sample to contain only water-soluble sub-
stances. Also, high temperature applied during the water
extraction process might have affected the potency of
proteins within the EBN, possibly through denaturation.
Based on the observations, it is likely that the water-
soluble substances possess less cytotoxic effect compar-
ing to S1, the crude EBN extract.
EBN extracts prevent 6-OHDA-induced apoptotic changes
in SH-SY5Y cells
A number of cellular morphological changes including
cytoplasmic condensation resulting in reduced cell size,
plasma membrane undulations or blebbing, condensation
of chromatin at nuclear periphery, dilatation of endoplas-
mic reticulum and formation of apoptotic bodies represent
the typical characteristics of apoptosis [29,30]. In the
present study, changes in cellular morphology of SH-SY5Y
upon different treatments were assessed by microscopic
examination. Untreated SH-SY5Y cells had a distinctive
neuronal shape with typical long neurite outgrowth. In
addition, cell membrane was intact and there were min-
imal dead cells (Figure 2A). Nuclear staining with DNA-
binding fluorescent dye Hoechst 33258 showed homo-
genously stained regular rounded nuclei in control cells
(Figure 2E). However, when incubated with 100 μM
6-OHDA (an optimum concentration determined from
our studies earlier; Data not shown), cell death was made
evident by the presence of shiny, floating and round-
shaped cells under bright field microscopy (Figure 2B).
Shrinking cells which gradually lost their elongated neur-
onal shape and have shrunken in size were also detected
(yellow arrow in Figure 2B). Meanwhile, increased number
of bright fluorescent nuclei indicative of chromatin con-
densation (white arrow in Figure 2F), as well as nuclear
fragmentation (red arrow in Figure 2F) were apparent
after Hoechst staining. Smaller asymmetrical nuclei
were also seen as a result of cell shrinkage (green arrow
in Figure 2F). These features altogether suggest that 6-
OHDA-induced SH-SY5Y cell death was likely to be
mediated through apoptosis. This finding is supported
by previous study which concluded that the selective
catecholaminergic neurotoxin induces oxidative stress-
associated cell death primarily through apoptosis [31].
Nonetheless, pre-treatment with S1 or S2 for 24 hours
prior to the addition of 6-OHDA conferred protection to
SH-SY5Y cells by reducing cell death in the culture
(Figure 2C-D). In addition, the nuclear apoptotic changes
induced by 6-OHDA were less noted in the cells after pre-
treatment with S1 and S2 (Figure 2G-H), suggesting that
Figure 1 Cytotoxic effect of EBN extracts on SH-SY5Y cells. Cytotoxicity percentage of SH-SY5Y cells upon 48 hours treatment with either S1
or S2 was tested across a wide range of concentration from 0 to 500 μg/ml and MTT assay was carried out. Maximum non-toxic dose was then
determined from the graph. The data shown are means ± S.D. of three independent experiments performed in triplicates.
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S1 improves cell viability in 6-OHDA-challenged SH-SY5Y
cells
To quantify the cell viability from those observed in the
morphological study, MTT assay was performed. Upon
challenge with 100 μM 6-OHDA for 24 hours, cell viability
decreased significantly to about 40% of that of control
(Figure 3). Pre-treatment with EBN extracts followed by
co-incubation with 6-OHDA generally did not improve
cell viability except in the cells treated with S1 at re-
spective MNTD. About 20% increase in the cell viabil-
ity was observed under that treatment as compared to
the 6-OHDA group. This could be due to mitogenic
property of S1 that promoted cell growth, as made evident
by a study by Zainal Abidin et al. which shows that EBN
promoted cell division in rabbit corneal keratocytes [32].
Moreover, acid hydrolysates of EBN have been shown to
promote proliferation of human colonic adenocarcinoma
(Caco-2) cells [33]. The same report also pointed out that
sialic acid treatment alone induced significant Caco-2 pro-
liferation. Taken together the finding by Yagi et al. which
showed that sialic acid was present in EBN, it is suggested
that sialic acid could be the bioactive compound that we
are interested in [17].
On the contrary, S2 in overall did not prevent cell death,
which may be explained by the lower activity associated
with the water extract discussed earlier. Meanwhile, EBNtreatment alone for 48 hours did not affect cell survival, in-
dicating that EBN treatments at MNTDs were non-
cytotoxic to SH-SY5Y cells.
S2 attenuates ROS build up in 6-OHDA-challenged SH-
SY5Y cells
The overall oxidative status in SH-SY5Y cells was
assessed with the DCFH-DA assay. Figure 4 showed that
ROS was maintained at basal level when SH-SY5Y cells
were treated with EBN extracts alone, indicating that
EBN alone did not induce oxidative stress within the
cell. Furthermore, S2 caused significant drop in ROS
production suggesting the protective role of EBN as a
free radical species scavenger.
Intracellular ROS production was augmented by 4 fold
upon 6-OHDA exposure when compared to control
group. Pre-treatment with S1 at high dose (MNTD) did
not restore ROS to the basal level, but instead promoted
intracellular ROS build up twice as much as the level of
that in cell treated with 6-OHDA alone. This could be
due to the presence of reactive compounds in S1 which
prompted the generation of extra free radical in cells on
top of the existing oxidative load, for example a 66 kDa
major allergen protein in EBN [34]. As allergenic im-
mune reaction is often linked to increased intracellular
ROS production, this putative protein possesses homology
to a domain of an ovoinhibitor precursor in chicken could
possibly be the contributor of intracellular ROS load in S1-
treated SH-SY5Y cells [35,36].
Figure 2 Effect of EBN extracts on morphological and nuclear changes of 6-OHDA-challenged SH-SY5Y cells. Microscopic images were
taken after 48 hours of treatment. Figures A-D are bright field images while Figures E-H are fluorescent images taken after Hoechst 33258 staining.
Figures A and E: control group; Figures B and F: 6-OHDA group; Figures C and G: S1 MNTD + 6-OHDA-treated group; Figures D and H: S2
MNTD + 6-OHDA-treated group. Cell shrinkage is indicated by cell losing its distinctive neuronal shape and has becomes smaller in size
(yellow arrow in Figure 2B), DNA fragmentation is indicated by cluster of nuclei fragments (red arrow in Figure 2F), shrunken cell is indicated
by smaller and distorted nuclei (green arrow in Figure 2F) while nuclear chromatin condensation is indicated by brightly fluorescent nuclei
(white arrow in Figure 2F).
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ated to sub-control level by S2 treatment, in which high
dose seemed to suppress ROS production better than
low dose. These findings suggest that the water-soluble
compounds in S2 could be more effective in scavenging
intracellular ROS if present in high dose, whereas in
crude extract high dose would do the opposite effect.
The difference in activities of S1 and S2 can be inferred
from the different methods used in extract preparation.
Although both extracts derived from the same rawmaterial, solubility and solvent accessibility of bioactive
compounds in crude and water extracts may affect their
chemical properties and hence, the bioactivities. In par-
ticular, water extraction method involves heat treatment
at 100°C and therefore may modify tertiary con-
formational structure of the native EBN protein. This
manipulation could possibly uncover the nucleophilic
amino acid residues that present in the protein core,
such as cysteine’s sulfhydryl groups [37]. These amino
acid residues are free radical scavenger because they are
Figure 3 Effect of EBN extracts on 6-OHDA-challenged SH-SY5Y cell viability. Cell viability was assessed with MTT assay and data shown are
means ± S.D. of three independent experiments performed in triplicates. *P < 0.05; **P < 0.01; ***P < 0.001 versus untreated control cells while
#P < 0.05, ##P < 0.01; ###P < 0.001 versus 6-OHDA treated cells.
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S2 may therefore possess higher antioxidant potential
than S1 because of greater solvent exposure of free rad-
ical scavenging amino acid residues as a result of heat-
assisted protein denaturation.
Generally, reduction of ROS level would ameliorate
oxidative stress-related cellular damage and cell death,
but this was not observed in the present study. Results
from ROS measurement when put together with MTT
results raised an intriguing question because S1 had suc-
cessfully improved cell viability although it triggered
ROS generation. One explanation for this is that S1
could have initiated cytoprotective mechanism other
than direct ROS-scavenging, such as the promotion ofFigure 4 Effect of EBN extracts on intracellular reactive oxygen specie
Intracellular ROS levels of treated groups were assessed with DCFH-DA assay an
performed in triplicates. *P < 0.05; **P < 0.01; ***P < 0.001 versus untreated contrantioxidant defense system through nuclear erythroid 2-
related factor 2 - antioxidant responsive element (Nrf2-
ARE) signaling [38]. It has been suggested that exogenous
protein can act through Nrf2-ARE signaling pathway
to induce expression of endogenous antioxidant enzymes
[39]. In fact, ARE activation have been demonstrated to be
protective against in vitro cell death induced by dopamine
and 6-OHDA, likely due to enhanced expression of the
antioxidant proteins such as glutathione S-transferase A2,
heme oxygenase-1 and NAD(P)H quinoneoxidoreductase 1
[40-42]. Interestingly, Nrf2-ARE activation is a redox-
sensitive process thus this process can be triggered in re-
sponse to intracellular oxidative changes, as seen in the ac-
tion of apomorphine whereby ROS produced by the drugs (ROS) production in 6-OHDA-challenged SH-SY5Y cells.
d data shown are means ± S.D. of three independent experiments
ol cells while #P < 0.05, ##P < 0.01; ###P < 0.001 versus 6-OHDA treated cells.
Figure 5 Effect of EBN extracts on 6-OHDA-induced apoptosis
in SH-SY5Y cells. Cells treated with EBN extracts for 48 hours were
analyzed by Annexin V-propidium iodide double staining.
Representative plots of propidium iodide versus Annexin V-FITC
fluorescence signals are shown (A-J). Results shown are the mean ± S.D.
of three independent experiments. *P < 0.05; **P < 0.01 versus untreated
control cells while #P < 0.05, ##P < 0.01; ###P < 0.001 versus 6-OHDA
treated cells.
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fore, it is possible that S1, in the presence of ROS, generates
signals that initialize molecular changes to result in cyto-
protection and hence improved cell viability. However, fur-
ther works should be done to confirm the role of these
members of the intracellular antioxidant response system
in the neuroprotective mechanism of S1. Investigations on
expression of the antioxidant genes or proteins, and nuclear
translocation of Nrf2 protein could be performed in the
future.
EBN extracts reduce early apoptotic event in 6-OHDA-
challenged SH-SY5Y cells
Apoptotic event was investigated by Annexin V-PI double
staining method to identify the mode of cell death. Several
previous reports showed that apoptosis of dopaminergic
neurons was found to increase with 6-OHDA-induced oxi-
dative stress [45-48]. In this assay, cells residing at different
stages of apoptosis upon exposure to 6-OHDA were identi-
fied by differential staining of membrane phosphatidylser-
ine and DNA, whereby cells are grouped and represented
in dot plot as healthy (lower left quadrant), early apoptotic
(lower right quadrant), late apoptotic (upper right quad-
rant) and necrotic (upper left quadrant) ones. Early apop-
tosis, represented by cell stained positively with Annexin V
due to phosphatidylserine translocation towards outer
membrane surface followed by loss of membrane integrity,
was found to be the major cell death mechanism in cell
treated with 6-OHDA for 24 hours. It accounted for about
30% of the cell population (Figure 5B, lower right quad-
rant), which is in concordance with other reports [49,50].
Generally EBN treatment alone did not stimulate
apoptotic event (Figure 5D-F), but it effectively reduced
early apoptotic injury in cells challenged with 6-OHDA
(Figure 5H-J). The results suggest that EBN is a potential
neuroprotective agent which acts by inhibiting apoptosis.
However, S1 treatment increased the percentage of
apoptotic population in normal culture (Figure 5C) and
did not reduced the early apoptosis induced by 6-OHDA
(Figure 5G) when given at MNTD. Such findings
imply that high dose of crude extract did not improve
apoptosis and could have itself contributed to apop-
tosis in SH-SY5Y cells, despite the fact that MNTD
used for S1 treatment had been pre-determined as
non-toxic. The apoptosis-inducing nature of S1 at
MNTD may be related to the elevated intracellular
ROS produced as determined from the DCFH-DA
assay previously.
EBN extracts did not improve mitochondrial dysfunction
in 6-OHDA-challenged SH-SY5Y cells
Mitochondrial dysfunction as defined by collapse in
MMP is an early and critical event in cellular apoptosis.
In fact, the opening of mitochondrial transition pore
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mitochondrial potential, subsequently leading to in-
creased mitochondrial permeability and thus the efflux
of pro-apoptotic factors such as cytochrome c and pro-
caspases [51]. The MMP in SH-SY5Y cells was measured
in order to study the alteration in mitochondrial activity
during apoptosis. In the present study, MMP of SH-
SY5Y cells dropped drastically to 27% of that in control
when the cell was exposed to 100 μM 6-OHDA for
24 hours (Figure 6). Although the action through which
6-OHDA induces cytotoxicity in neuronal cell lines such
as SH-SY5Y and PC12 has been linked to ROS outburst,
literature is available to show that failure of cellular re-
spiratory complex may be the direct cause of apoptosis.
Gomez- Lazaro et al. found that mitochondrial fragmen-
tation constitutes early event in mitochondrial dysfunc-
tion and eventually cell death of SH-SY5Y. The author
further revealed that 6-OHDA-induced SH-SY5Y cell
death was reversible by blockage of the mitochondrial
fission activity [51]. Taken together, the findings support
the indispensable role of mitochondrial integrity in SH-
SY5Y cells’ survival. In fact, studies have successfully
demonstrated neuroprotection against apoptosis via res-
toration of mitochondrial functionality by natural prod-
ucts, such as the herbal medicine Chunghyuldan, which
ameliorated PD-like behavioral symptoms by preserving
dopaminergic neurons in the nigrostriatal region of PD
mice model [52].
Yet, mitochondrial functionality in the intoxicated cell
was not improved with EBN treatment in the present study.
There was no significant difference in MMPs between the
EBN-co-treated and 6-OHDA groups. Therefore, the cell-
promoting effect of S1 seen in MTT assay may be notFigure 6 Effect of EBN extracts on mitochondrial membrane potentia
with mitochondria-selective JC-1 dye and results shown are the mean ± S.D
untreated control cells while #P < 0.05 versus 6-OHDA treated cells.related to resuscitation of MMP in 6-OHDA-challenged
SH-SY5Y cells. Although 6-OHDA-induced cytotoxicity is
mainly associated with mitochondrial respiratory dysfunc-
tion, an opposite mitochondrial-independent pathway is as
well indicated in a number of studies [53,54]. As such, in-
volvement of non-mitochondrial mechanism may be impli-
cated in the neuroprotection conferred by the EBN crude
extract.
Notably, EBN treatment alone was shown to bring
down the level of MMP significantly, indicating that the
addition of foreign compound to the SH-SY5Y culture
could affect the mitochondrial status. Still, treatment
with EBN extracts alone for 48 hours did not exhibit any
detrimental effect on the SH-SY5Y’s cell viability and
oxidative status.
S2 inhibits cleavage of caspase-3 in 6-OHDA-challenged
SH-SY5Y cells
Caspase-3 is the executioner protein of the apoptotic
process and remains as inactive procaspase until it is be-
ing cleaved by activated initiator caspases such as
caspase-8 or caspase-9. Its activation leads to down-
stream mechanisms which involve poly(ADP-ribose)
polymerase-mediated DNA cleavage and breakdown of
proteins essential for maintenance of cytoskeletal struc-
ture. Eventually, activation of caspase-3 results in DNA
fragmentation and apoptosis [55].
Elevated active caspase-3 level was detected in SH-
SY5Y cells treated with 6-OHDA, which was 7.8% as
compared to 3.5% in control (Figure 7). However, S2 at
½ MNTD managed to attenuate caspase-3 activation in
the cell. This explains the parallel reduction in early
apoptotic population by S2 at ½ MNTD as seen froml (MMP) in 6-OHDA-challenged SH-SY5Y cells. MMP was assessed
. for three independent experiments. *P < 0.05; **P < 0.01 versus
Figure 7 Effect of EBN extracts on cleavage of caspase-3 in SH-SY5Y cells challenged with 6-OHDA. The release of active caspase-3 into
cytosol was assessed by immunostaining using FITC-conjugated antibody and results were generated from flow cytometry. Results shown are the
mean ± S.D. of three independent experiments. **P < 0.05; **P < 0.01 versus untreated control cells while #P < 0.05, ##P < 0.01versus 6-OHDA
treated cells.
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caspase-3 activation in the process of 6-OHDA-induced
SH-SY5Y apoptosis [56].
Caspase-3 can be activated through two machineries,
namely the mitochondria-related apoptosis protease-
activating factor-1/caspase-9/caspase-3 cascade, and Fas-
associated adapter protein/caspase-8/caspase-3 cascade
which is the extrinsic apoptotic pathway [57]. Based on
the observation from MMP assay in which S2 failed to
resuscitate mitochondrial depolarization in SH-SY5Y
cells challenged with 6-OHDA, it is likely that S2 inhibited
caspase-3 through modulation of the extrinsic pathway
which has little relation to the mitochondrial activity.
However, future study is warranted to investigate the in-
volvement of extrinsic pathway in S2-mediated neuropro-
tection. For EBN treatment only, both S1 and S2 when
given at MNTD induced release of active caspase-3, signi-
fying that high dose of the extracts may trigger early apop-
tosis event and hence lower concentrations should be used
for the treatment.
Remarks on discordance between cytotoxicity and
apoptotic parameters
Current finding showed that S1 treatment at MNTD im-
proved SH-SY5Y cell viability despite being unable to
prevent apoptosis and restore ROS and caspase-3 to
basal level. On the contrary, S2 treatment has success-
fully attenuated ROS development and reduced apoptosis
and caspase-3 release, yet it failed to reverse cytotoxic ef-
fect of 6-OHDA. This is intriguing as cytotoxicity is posi-
tively associated with apoptotic event, oxidative stress and
caspase-3 activation. However, it is worth mentioning thatcytotoxicity can be mediated by several different cell death
mechanisms. Other than apoptosis, cell death can also be
orchestrated by autophagy and necrosis [58]. Under such
circumstances, cells are likely to either slowly sequestrated
and then degraded by autolysomes through autophagy, or
undergo necrosis upon activation of death domain re-
ceptors on cell surface. Cytotoxicity is thus attributed,
but not exclusively, to apoptosis parameters such as exter-
nalization of phosphatidylserine on plasma membrane
and activation of caspase signaling cascade. Meanwhile
caspase-dependent cell death mechanism has often been
described as cardinal to 6-OHDA-induced apoptosis in
SH-SY5Y cells, it is proposed that another caspase-
independent mechanism may also exist in a cell death sce-
nario [59]. Such claim is supported by literatures, stating
that in dying cells, caspase inhibition alone does not neces-
sary grant full resuscitation from apoptosis but may switch
cell death to alternative autophagic or necrotic modes in-
stead [60,61]. In fact, dysregulation of autophagic response
in the neurons has been linked to PD incidence [62] and
autophagic changes in SH-SY5Y cells are inducible with 6-
OHDA treatment [63]. On the other hand, oxidative burst
from 6-OHDA could contribute to membrane rupture and
therefore necrosis in neurons too [64]. Considering that
autophagy or other cell death mechanisms could be acti-
vated and participated in regulating cell death in our PD
cell model, hence it is indefinite that inhibition of apop-
tosis or caspase activation by S2 treatment would see cor-
responding decrease in cell death or cytotoxicity. This may
partly explain the failure of S2 extract to counteract cyto-
toxicity due to 6-OHDA exposure regardless of its ability
to attenuate apoptosis and caspase-3 cleavage.
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It has been successfully demonstrated that EBN extracts
confer neuroprotection in 6-OHDA-challenged SH-
SY5Y cell model. Particularly, S1 demonstrated neuro-
protective potential by improving cell viability while S2
inhibited oxidative stress and caspase-3 activation. Both
the EBN extracts shown to inhibit apoptosis. Further in-
vestigation is needed to identify and elaborate the prop-
erties of the bioactive compounds in EBN that are
responsible for the neuroprotective benefits. In sum-
mary, the present study suggests that EBN may be ef-
fective in the treatment of neurodegenerative diseases
where oxidative stress plays a causal role.
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